266 related articles for article (PubMed ID: 34062596)
1. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
[No Abstract] [Full Text] [Related]
2. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Hashemi A; Madhavan MV; Bikdeli B
Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
[No Abstract] [Full Text] [Related]
3. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
Lippi G; Henry BM; Sanchis-Gomar F
Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
[No Abstract] [Full Text] [Related]
4. Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
Arachchillage DRJ; Shi C; Saliu D; Kozman P; Mi E; Buti N; Kashef E; Copley SJ; Gomez C; Leonard R; Aziz R; Shlebak AA; Laffan M
Semin Thromb Hemost; 2021 Jun; 47(4):436-441. PubMed ID: 33482676
[No Abstract] [Full Text] [Related]
5. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Horowitz NA; Brenner B
Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
[No Abstract] [Full Text] [Related]
6. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
Kazmi S; Herekar F; Sarfaraz S
Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
[No Abstract] [Full Text] [Related]
7. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
[No Abstract] [Full Text] [Related]
8. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
Harenberg J; Bauersachs R; Ageno W
Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
[No Abstract] [Full Text] [Related]
9. Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.
Patel R; Czuprynska J; Roberts LN; Vadher B; Rea C; Patel R; Gee E; Saul G; Coles E; Brown A; Byrne R; Speed V; Patel JP; Arya R
Thromb Res; 2021 Jan; 197():192-194. PubMed ID: 33227656
[No Abstract] [Full Text] [Related]
10. [Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?].
Hardy M; Douxfils J; Dogné JM; Lessire S; Chatelain B; Testa S; Gouin-Thibault I; Gruel Y; Lecompte T; Mullier F
Ann Biol Clin (Paris); 2020 Oct; 78(5):471-481. PubMed ID: 33026344
[TBL] [Abstract][Full Text] [Related]
11. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM
Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668
[No Abstract] [Full Text] [Related]
12. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2020 Oct; 46(7):757-762. PubMed ID: 33080660
[No Abstract] [Full Text] [Related]
13. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
[TBL] [Abstract][Full Text] [Related]
14. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 epidemic: anticoagulants treatments, another victim.
Lapostolle F; Vianu I; Petrovic T; Adnet F
Acta Cardiol; 2021 Apr; 76(2):222-223. PubMed ID: 33308093
[No Abstract] [Full Text] [Related]
16. Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
Pancani R; Villari L; Foci V; Parri G; Barsotti F; Patrucco F; Malerba M; Vincenti R; Carrozzi L; Celi A
Thromb Res; 2021 Jan; 197():44-47. PubMed ID: 33181470
[TBL] [Abstract][Full Text] [Related]
17. 30 years of developmental haemostasis: what have we learnt and how are we applying this knowledge.
Ignjatovic V
Thromb Res; 2018 Dec; 172():188-189. PubMed ID: 30522639
[No Abstract] [Full Text] [Related]
18. Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review.
Słomka A; Kowalewski M; Żekanowska E
Thromb Haemost; 2021 Sep; 121(9):1181-1192. PubMed ID: 33401332
[TBL] [Abstract][Full Text] [Related]
19. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2022 Feb; 48(1):3-7. PubMed ID: 35104908
[No Abstract] [Full Text] [Related]
20. Thrombosis in childhood cancer.
Allen GA; Bhat R
Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
